173 filings
10-Q
2024 Q1
SRZN
Surrozen Inc
Quarterly report
8 May 24
4:18pm
8-K
SRZN
Surrozen Inc
8 May 24
Surrozen Provides First Quarter 2024 Financial Results and Business Update
4:12pm
EFFECT
SRZN
Surrozen Inc
26 Apr 24
Notice of effectiveness
12:15am
424B5
SRZN
Surrozen Inc
25 Apr 24
Prospectus supplement for primary offering
4:28pm
ARS
2023 FY
SRZN
Surrozen Inc
23 Apr 24
Annual report to shareholders
4:30pm
DEFA14A
wlnz43b34qtgkju9
23 Apr 24
Additional proxy soliciting materials
4:28pm
D
im9p7c6afy9tsr sj
19 Apr 24
$193.02 mm in equity / options / securities to be acquired, sold $193.02 mm, 18 investors
3:38pm
S-8
7prxvh xdu6vo2yc
10 Apr 24
Registration of securities for employees
4:53pm
8-K
j1dok
2 Apr 24
Entry into a Material Definitive Agreement
5:07pm
NT 10-K
a6een282rhx
2 Apr 24
Notice of late annual filing
4:21pm
8-K
mxinuy
1 Apr 24
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
8:52am
424B3
ks0i6xt9 8ur0ctl41
7 Feb 24
Prospectus supplement
6:16am
8-K
hots8ho71v03 ldmfm
7 Feb 24
Departure of Directors or Certain Officers
6:10am
424B3
cpqo88pk
22 Jan 24
Prospectus supplement
5:24pm
8-K
nn5tvetj
18 Jan 24
Other Events
8:41am
424B3
lovdhts
13 Dec 23
Prospectus supplement
5:21pm
8-K
3nkraop5
13 Dec 23
Amendments to Articles of Incorporation or Bylaws
5:14pm